Vaxart director Breitmeyer files initial Form 3

Vaxart, Inc. director James B. Breitmeyer filed an initial Form 3, which is a statement of beneficial ownership for insiders.

Rhea-AI Filing Summary

Vaxart, Inc. director James B. Breitmeyer filed an initial Form 3, which is a statement of beneficial ownership for insiders. This filing lists him as a director of Vaxart but does not report any share purchases, sales, or other transactions in the company’s securities.

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"filed an initial Form 3, which is a statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"an initial Form 3, which is a statement of beneficial ownership for insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"The Form 3 shows that James B. Breitmeyer is the reporting person"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Vaxart (VXRT) Form 3 for James B. Breitmeyer show?

The Form 3 shows that James B. Breitmeyer is a director of Vaxart, Inc.. It is an initial statement of beneficial ownership and does not list any transactions in Vaxart securities.

Did James B. Breitmeyer buy or sell VXRT shares in this Form 3?

No. The Form 3 for James B. Breitmeyer reports zero purchases, zero sales, and no derivative exercises. It serves only as an initial ownership statement without listing any trading activity.

Why is a Form 3 filed for Vaxart (VXRT) director James B. Breitmeyer?

A Form 3 is filed when someone becomes an insider, such as a director. It provides the SEC and investors with an initial record of that person’s beneficial ownership in Vaxart, Inc..

Does the Vaxart (VXRT) Form 3 include any derivative securities for Breitmeyer?

No. The filing’s derivative summary is empty, indicating no listed options, warrants, or other derivative positions for James B. Breitmeyer in this initial Form 3 disclosure.

What trading direction can be inferred from the VXRT Form 3 for Breitmeyer?

None. The transaction summary shows no buys, sells, acquisitions, or dispositions. The net buy/sell direction is recorded as neutral, reflecting the absence of any reported transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 08:54 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BREITMEYER JAMES B

(Last) (First) (Middle)

C/O VAXART, INC.

310 UTAH AVENUE, SUITE 150

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/23/2026

3. Issuer Name and Ticker or Trading Symbol
Vaxart, Inc. [ VXRT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Edward Berg, as attorney-in-fact for James B. Breitmeyer	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)